Antidepressant drugs in the elderly

被引:17
作者
Gareri, P
Stilo, G
Bevacqua, I
Mattace, R
Ferreri, G
De Sarro, G
机构
[1] Policlin Materdomini, Dipartimento Med Sperimentale & Clin, Cattedra Farmacol, Chair Pharmacol,Fac Med, I-88100 Catanzaro, Italy
[2] Policlin Materdomini, Dipartimento Med Sperimentale & Clin, Cattedra Farmacol, Chair Geriatr,Fac Med, I-88100 Catanzaro, Italy
[3] Casa Cura S Vincenzo, I-88100 Catanzaro, Italy
来源
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM | 1998年 / 30卷 / 04期
关键词
elderly; pharmacokinetics; pharmacodynamics; depression; tricyclics; atypical antidepressants; MAO inhibitors; lithium;
D O I
10.1016/S0306-3623(97)00070-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. In this article some of the most important and tolerated drugs in the elderly are reviewed. 2. Tricyclic antidepressants have to be used carefully because of their important side effects. Nortriptyline and desipramine appear to be the best tolerated tricyclics in old people. 3. Second generation antidepressants are preferred for the elderly and those patients with heart disease as they have milder side effects and are less toxic in overdose. 4. MAO inhibitors are useful drugs in resistant forms of depression in which the above mentioned drugs have no efficacy and the last generation drugs (reversible MAO inhibitors), such as moclobemide, seem to be very successful. 5. Lithium is sometimes used especially to prevent recurrence of depression, even if its use is limited in old patients due to its side effects. 6. Psychotherapy is often used as an adjunct to pharmacotherapy, while electroconvulsant therapy is used only in the elderly patients with severe depression, high risk of suicide, or drug resistant forms. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:465 / 475
页数:11
相关论文
共 96 条
[1]  
ABERNETHY DR, 1985, J PHARMACOL EXP THER, V232, P183
[2]   THE PROGNOSIS OF DEPRESSION IN OLD-AGE - THE CASE FOR LITHIUM-THERAPY [J].
ABOUSALEH, MT ;
COPPEN, A .
BRITISH JOURNAL OF PSYCHIATRY, 1983, 143 (NOV) :527-528
[3]   STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE INTWINS - INFLUENCE OF GENETIC FACTORS AND DRUG THERAPY [J].
ALEXANDERSON, B ;
EVANS, DAP ;
SJOQVIST, F .
BMJ-BRITISH MEDICAL JOURNAL, 1969, 4 (5686) :764-+
[4]  
ALLEN MR, 1987, GERIATRICS, V4, P51
[5]   THE PHARMACOLOGY OF REVERSIBLE MONOAMINE-OXIDASE INHIBITORS [J].
AMREIN, R ;
ALLEN, SR ;
GUENTERT, TW ;
HARTMANN, D ;
LORSCHEID, T ;
SCHOERLIN, MP ;
VRANESIC, D .
BRITISH JOURNAL OF PSYCHIATRY, 1989, 155 :66-71
[6]  
AUSTER R, 1993, AM FAM PHYSICIAN, V48, P311
[7]   RISK-FACTORS IN GERIATRIC DRUG PRESCRIBING - A PRACTICAL GUIDE TO AVOIDING PROBLEMS [J].
BEERS, MH ;
OUSLANDER, JG .
DRUGS, 1989, 37 (01) :105-112
[8]   CURRENT CONCEPTS DEPRESSION IN THE ELDERLY [J].
BLAZER, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (03) :164-166
[9]   BLOCKADE BY NEWLY-DEVELOPED ANTIDEPRESSANTS OF BIOGENIC-AMINE UPTAKE INTO RAT-BRAIN SYNAPTOSOMES [J].
BOLDENWATSON, C ;
RICHELSON, E .
LIFE SCIENCES, 1993, 52 (12) :1023-1029
[10]   DRUG-THERAPY FOR GERIATRIC DEPRESSION [J].
BRESSLER, R ;
KATZ, MD .
DRUGS & AGING, 1993, 3 (03) :195-219